Physician profile
Rasheed Onafuye
NPI 1669651667
$2,695.17
in general payments reported to CMS, 2019-2025
16 companies · $341 in 2025
The $341 reported for 2025 was more than what a typical Geriatric Psychiatry provider received nationally (typical 2025 total: $125).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $34.03 · 2022: $217 · 2023: $220 · 2024: $1,883 · 2025: $341.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,572 · Travel and Lodging: $873.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,571.74 |
| Travel and Lodging | $872.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neuronetics, INC. | $1,921.72 | 2024-2025 | Neurostar Tms Therapy System |
| Amgen INC. | $125.00 | 2024 | Krystexxa |
| Horizon Therapeutics Plc | $116.56 | 2023 | Krystexxa |
| Janssen Pharmaceuticals, INC | $105.53 | 2020-2024 | Spravato |
| Supernus Pharmaceuticals, INC. | $95.02 | 2022-2024 | Qelbree |
| Abbvie INC. | $71.77 | 2022-2025 | |
| Otsuka America Pharmaceutical, INC. | $60.59 | 2022-2024 | Rexulti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $40.41 | 2023-2024 | Caplyta |
| Lundbeck LLC | $36.82 | 2023 | Rexulti |
| E.R. Squibb & Sons, L.L.C. | $33.83 | 2024-2025 | Cobenfy |
| Axsome Therapeutics, INC. | $31.61 | 2024 | Auvelity |
| Indivior INC. | $27.25 | 2022 | |
| Neos Therapeutics, LP | $15.19 | 2022 | |
| Allergan, INC. | $13.87 | 2020 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rasheed Onafuye listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.